A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/11/2006	EP1708676A2 Methods and compositions for facilitating metabolic control
10/11/2006	EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists
10/11/2006	EP1529041B1 Novel prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridil-n-2-hydroxycarbonylethyl)-amide, production and use thereof as medicaments
10/11/2006	EP1478629B1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
10/11/2006	EP1471896B1 Formulations for inhalation
10/11/2006	EP1469851B1 Melanocortin receptor agonists
10/11/2006	EP1430045B1 Pyrane derivatives as both ace- and nep-inhibitors
10/11/2006	EP1399150A4 Vitamin c compositions
10/11/2006	EP1363903B1 Indole derivatives and their use as gnrh antagonists
10/11/2006	EP1363509B1 Compositions containing creatine and creatinine
10/11/2006	EP1340757B1 1-methylcarbapenem derivatives
10/11/2006	EP1306375B1 Salts of benzimidazole compound and application thereof
10/11/2006	EP1303258B1 Novel aerosol formulation containing a polar fluorinated molecule
10/11/2006	EP1299091B1 Matrix controlled transdermal system for stabile derivatives of ace inhibitors
10/11/2006	EP1289511A4 Bactericidal preparation
10/11/2006	EP1226212B1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof
10/11/2006	EP1216232B1 Heterocyclic compounds and methods for modulating cxcr3 function
10/11/2006	EP1183250B1 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
10/11/2006	EP1181013B1 Method and composition for the treatment of cancer
10/11/2006	EP1147134B1 Novel potassium channels and genes encoding these potassium channels
10/11/2006	EP1133311B1 INFLUENCING ANGIOGENESIS USING CD66a
10/11/2006	EP1128835B9 Cyanocobalamin (vitamin b 12) treatment in allergic disease
10/11/2006	EP1107959B1 Quinazoline derivatives as medicaments
10/11/2006	EP1107807B1 Use of citrate in a catheter lock solution
10/11/2006	EP1049465B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/11/2006	EP0983070B1 Prevention of ovarian cancer by administration of a vitamin d compound
10/11/2006	EP0982990B1 Stable liquid calcium ascorbate compositions and methods of manufacture and use
10/11/2006	EP0954565B1 Adipogenic differentiation of human mesenchymal stem cells
10/11/2006	EP0944619B1 Novel integrin receptor antagonists
10/11/2006	EP0914448B1 Lipid kinase
10/11/2006	EP0896586B1 ErbB3 ANTIBODIES
10/11/2006	EP0894000B1 Use for delivering estrogen
10/11/2006	EP0832225B1 Chimeric proteins for use in transport of a selected substance into cells
10/11/2006	EP0814803B1 Use of steroidal estrogen receptor antagonists as male contraceptives
10/11/2006	EP0751782B1 Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone for enhancing fertility
10/11/2006	CN1846456A Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
10/11/2006	CN1845933A Specific glucocorticosteriod compound having anti-inflamatory activity
10/11/2006	CN1845932A Transfection agents
10/11/2006	CN1845927A Microcrystal and medicinal preparation containing the same
10/11/2006	CN1845926A Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
10/11/2006	CN1845924A Arylamine-substituted quinazolinone compounds
10/11/2006	CN1845922A Benzimidazolone compounds having 5-HT4 receptor agonistic activity
10/11/2006	CN1845920A 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/11/2006	CN1845917A 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicam
10/11/2006	CN1845916A 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
10/11/2006	CN1845915A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
10/11/2006	CN1845914A Ophthalmic compositions for treating ocular hypertension
10/11/2006	CN1845911A Condensed ring compound and use thereof
10/11/2006	CN1845909A Quinoxaline derivatives as neutrophil elastase inhibitors and their use
10/11/2006	CN1845908A 5-substituted quinazolinone derivatives
10/11/2006	CN1845907A Guanidine derivatives
10/11/2006	CN1845906A Selective synthesis of CF3-substituted pyrimidines
10/11/2006	CN1845905A PPAR-activating compound and pharmaceutical composition comprising the compound
10/11/2006	CN1845904A Ophthalmic compositions for treating ocular hypertension
10/11/2006	CN1845900A Quinoline derivatives as neutrophil elastase inhibitors and their use
10/11/2006	CN1845897A 取代的四环素化合物 Substituted tetracycline compound
10/11/2006	CN1845750A Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
10/11/2006	CN1845746A Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents
10/11/2006	CN1845745A Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
10/11/2006	CN1845744A The combination of a serotonin reuptake inhibitor and amoxapine
10/11/2006	CN1845743A Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
10/11/2006	CN1845742A Method of stabilizing diarylvinylene compound
10/11/2006	CN1845741A TRP-P8 active compounds and therapeutic treatment methods
10/11/2006	CN1845740A Piperazine derivatives for the treatment of HIV infections
10/11/2006	CN1845739A Compositions comprising benzo (G) quinoline derivatives and prostaglandin derivatives
10/11/2006	CN1845738A Composition for veterinary and medical use
10/11/2006	CN1845737A Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
10/11/2006	CN1845736A Methods related to the treatment of mucosal associated conditions
10/11/2006	CN1845735A Novel medical use of selective cb1-receptor antagonists
10/11/2006	CN1845734A Benzimidazole derivatives and their use as protein kinases inhibitors
10/11/2006	CN1845733A Tgf-beta gene expression inhibitor
10/11/2006	CN1845732A Composition for the treatment of vitiligo
10/11/2006	CN1845731A Combination therapy for glycaemic control
10/11/2006	CN1845730A The combination of a serotonin reuptake inhibitor and loxapine
10/11/2006	CN1845729A Pharmaceutical composition comprising I.A. vitamin C, magnesium, green tea extract for retarding cardiovascular diseases
10/11/2006	CN1845728A Pharmaceutical compositions and method of using levodopa and carbidopa
10/11/2006	CN1845727A Curing and prophylactic agent applied during the use of alcohol and psychoactive substances
10/11/2006	CN1845726A Erg channel openers for the treatment of cardiac arrhythmias
10/11/2006	CN1845723A Methods for the treatment of endometriosis
10/11/2006	CN1845721A Methods for administering aripiprazole
10/11/2006	CN1845717A Powdery compositions and skin preparation containing the same for external use
10/11/2006	CN1845683A Composition and method for facilitating bone healing
10/11/2006	CN1845674A Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
10/11/2006	CN1844164A Process for preparing carboxymethyl chitosan calcium and application thereof
10/11/2006	CN1844162A Process for preparing high purity pectin by using apple pomace
10/11/2006	CN1844161A Beta-1,4-glucan-6,2,3-sulfate and its preparation method and use
10/11/2006	CN1844160A Sulfonated changium root polysaccharides and preparing method and use thereof
10/11/2006	CN1844154A Optimization for extracting condition of Codonopsis pilosula polysaccharide
10/11/2006	CN1844153A Intracellular polysaccharide from Isaria farinosa
10/11/2006	CN1844139A Triterpene compounds with ring breakage in C3 and C4 position and their use for prevention and treatment of AIDS
10/11/2006	CN1844137A Preparation process of chromium glucosaminic acid and use thereof
10/11/2006	CN1844130A Maple extract and its use in preparation of free radical scavenger or antioxidant
10/11/2006	CN1844127A Caffeoyl guinic acid-1-phosphate and its preparation and use
10/11/2006	CN1844122A Benzoporphyrin chlorophyll photosensitizer and its preparation process and use
10/11/2006	CN1844121A Antipyretic analgesic and anti-arthritis nonsteroidal compound and its pharmaceutical compositions
10/11/2006	CN1844120A Aryl piperazine modified benzo [b] thiophene compounds and their preparation method and use
10/11/2006	CN1844118A Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor
10/11/2006	CN1844113A Hydroxy tanshinone IIA sodium sulfonate and its application
10/11/2006	CN1844106A Alkyl pyrazine phenolsulfonate and its preparation method and use
10/11/2006	CN1844105A Beta-elemene derivatives containing nitrogen and their preparation method and use

1 ... 4056 4057 4058 4059 4060 4061 4062 4063 4064 4065 4066 4067 4068 4069 4070 4071 4072 4073 4074 4075 4076 ... 7860